If you are a caregiver to an Alzheimer's patient who is suffering from agitation, please consider participating in a study to evaluate the potential benefit and safety of an investigational medication.
 
These behaviors are difficult for both patients and caregivers.  A
study medication is now being tested to see if it can work to treat agitation in
Alzheimer’s patients.
 
Symptoms of agitation in Alzheimer’s patients may include:
Pacing • Verbal aggression • Physical aggression • Other destructive behaviors
 
Two participating locations:
Dr Jagan Pillai -Cleveland Clinic, 9500 Euclid Avenue Cleveland, OH  44095
Dr. Babak Tousi- Lakewood Hospital, 1450 Belle Ave, Cleveland, OH  44107
 
Seeking patients ages 50-90 diagnosed with Alzheimer's disease and agitation severe enough to disrupt daily activities, for a 3 month study.
 
Patient must be accompanied by a caregiver. Compensation for time and expenses may be provided.
 
For More information:

 
Hilda Sosic, Research Coordinator @ Cleveland Clinic, Lou Ruvo Center for Brain Health 216-445-7273 email sosich@ccf.org
                                                        Or
Chris Whitman RN, Research Coordinator @ Lakewood Hospital, Senior CareAssessment Center 216-227-2438 email  whitmac@ccf.org

Research Study seeks interested Individuals at least 70 years old with no memory problems or with mild to moderate memory problems are invited to take part in a research study.*

• The study involves 2 visits spaced 12 months apart.
• Each visit will last approximately 2 hours and will involve questions about you and your health.
• There are no invasive procedures or medications.
• Participants will receive a stipend after completing each study visit.
• Study participants need to be able to read and speak English and complete written questionnaires.
  
  *This includes those diagnosed with Mild Cognitive Impairment
  or early Alzheimer’s disease.

Drs. Kathleen Smyth and Martha Sajatovic of the Neurological Outcomes Center are the study’s Principal Investigators. The goal of this study is to find the best way to measure the effects of future treatments to improve physical and mental function of older adults.

The study is funded by the National Institutes of Health.

For more information please contact
Nancy 216-368-2668 Nancy.Catalani@case.edu

Clinical Study

*endorsed by Greater Michigan Chapter MSAC

Cyndi Hovland-Scafe, former Family Services Manager for the Greater Michigan Chapter and social work student at the University of Wisconsin-Madison, is exploring caregivers' experiences with the death of a family member from a dementia-related diagnosis.  It is hoped that the results of this study will help professionals to understand better the physical, emotional, social and spiritual needs of family members caring for a loved one at the end of his or her life.

• Did you provide care to a family member age 65 or older who died from dementia within the past 6-18 months?

If so, would you be willing to share your experiences with Cyndi?  To participate in this study, Cyndi would meet with you at your home or other convenient location for a 60-90 minute interview.  For more information or to volunteer please contact:
Cyndi Hovland-Scafe
608-289-7518
chovsca@aol.com

Letter of Request

Alzheimer’s Disease & Cataract Removal Research Study

University Hospitals Case Medical Center, the MetroHealth Medical System, and Case Western Reserve University are now enrolling patients in a new, 5-year research study sponsored by the National Institutes of Health. 

In the study, we will learn more about how cataract removal impacts Alzheimer’s disease patients in their daily activities, their quality of life, their mood, and their performance on memory, cognitive, and visual tasks.

The duration of the study for each Participant will be approximately 6 months.  All study Participants will first be screened to determine if they are eligible and then randomly selected into one of two groups: Group A (immediate surgery group), or Group B (delayed surgery group).  Group A will have their cataract surgery within 1 month of enrolling in the study.  Group B will be asked to delay their cataract surgery for 6 months.

To be eligible, you must be at least 50 years or older, have a diagnosis of Alzheimer’s disease, have cataracts in both eyes, and know someone who can act as your “study partner.” 

To learn more about this study, please contact the University Hospitals Study Coordinator, Tatiana Riedel at 216-368-6465, (e-mail tjm6@case.edu), or the MetroHealth Study Coordinator, Alicia O’Brien at 216-778-2461 (e-mail aobrien@metrohealth.org).

Participants needed for
Center for Brain Health Study

Are you generally healthy, between the ages of 60 and 85, and have had a family member diagnosed with Alzheimer’s Disease? If so, you may be eligible for a new study being conducted at the Lou Ruvo Cleveland Clinic Center for Brain Health.

Please download the following 2 PDFs for more information about the study and how to participate 

    Click Here for a printable flyer         Click Her for  printable Brochure